226 related articles for article (PubMed ID: 23035734)
1. Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors.
Mignemi NA; Itani DM; Fasig JH; Keedy VL; Hande KR; Whited BW; Homlar KC; Correa H; Coffin CM; Black JO; Yi Y; Halpern JL; Holt GE; Schwartz HS; Schoenecker JG; Cates JM
Cancer Sci; 2012 Dec; 103(12):2173-80. PubMed ID: 23035734
[TBL] [Abstract][Full Text] [Related]
2. TGF-β and CTGF are Mitogenic Output Mediators of Wnt/β-Catenin Signaling in Desmoid Fibromatosis.
Varghese S; Braggio DA; Gillespie J; Toland AE; Pollock R; Mayerson J; Scharschmidt T; Iwenofu OH
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):559-565. PubMed ID: 26894649
[TBL] [Abstract][Full Text] [Related]
3. Signal transduction pathway analysis in fibromatosis: receptor and nonreceptor tyrosine kinases.
Cates JM; Black JO; Itani DM; Fasig JH; Keedy VL; Hande KR; Whited BW; Homlar KC; Halpern JL; Holt GE; Schwartz HS; Coffin CM
Hum Pathol; 2012 Oct; 43(10):1711-8. PubMed ID: 22520949
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pathogenesis of Sporadic Desmoid Tumours and Its Implications for Novel Therapies: A Systematised Narrative Review.
McLean TD; Duchi S; Di Bella C
Target Oncol; 2022 May; 17(3):223-252. PubMed ID: 35446005
[TBL] [Abstract][Full Text] [Related]
5. Expression profiles of sex steroid receptors in desmoid tumors.
Ishizuka M; Hatori M; Dohi O; Suzuki T; Miki Y; Tazawa C; Sasano H; Kokubun S
Tohoku J Exp Med; 2006 Nov; 210(3):189-98. PubMed ID: 17077595
[TBL] [Abstract][Full Text] [Related]
6. CTNNB1 Mutations and Estrogen Receptor Expression in Neuromuscular Choristoma and Its Associated Fibromatosis.
Carter JM; Howe BM; Hawse JR; Giannini C; Spinner RJ; Fritchie KJ
Am J Surg Pathol; 2016 Oct; 40(10):1368-74. PubMed ID: 27259010
[TBL] [Abstract][Full Text] [Related]
7. FAP-related desmoid tumors: a series of 44 patients evaluated in a cancer referral center.
Colombo C; Foo WC; Whiting D; Young ED; Lusby K; Pollock RE; Lazar AJ; Lev D
Histol Histopathol; 2012 May; 27(5):641-9. PubMed ID: 22419028
[TBL] [Abstract][Full Text] [Related]
8. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
[TBL] [Abstract][Full Text] [Related]
9. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
[TBL] [Abstract][Full Text] [Related]
10. PARP-1 expression as a prognostic factor in Desmoid-type fibromatosis.
Bräutigam K; Lindner J; Budczies J; Pahl S; Kunitz A; Melcher I; Wust P; Nebrig M; Baur A; Denkert C; Pfitzner B
Ann Diagn Pathol; 2020 Feb; 44():151442. PubMed ID: 31855806
[TBL] [Abstract][Full Text] [Related]
11. Cytokines associated with the pathophysiology of aggressive fibromatosis.
Mills BG; Frausto A; Brien E
J Orthop Res; 2000 Jul; 18(4):655-62. PubMed ID: 11052503
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
13. Utility of LEF1 to differentiate desmoid fibromatosis from its histologic mimics.
Jobbagy S; Lozano-Calderon S; Mullen JT; Nielsen GP; Hung YP; Chebib I
Virchows Arch; 2024 May; 484(5):807-813. PubMed ID: 38503969
[TBL] [Abstract][Full Text] [Related]
14. Targeting stem cell behavior in desmoid tumors (aggressive fibromatosis) by inhibiting hedgehog signaling.
Ghanbari-Azarnier R; Sato S; Wei Q; Al-Jazrawe M; Alman BA
Neoplasia; 2013 Jul; 15(7):712-9. PubMed ID: 23814483
[TBL] [Abstract][Full Text] [Related]
15. BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors.
Boeuf S; Bovée JV; Lehner B; van den Akker B; van Ruler M; Cleton-Jansen AM; Richter W
BMC Cancer; 2012 Oct; 12():488. PubMed ID: 23088614
[TBL] [Abstract][Full Text] [Related]
16. Desmoid tumor with ossification in chest wall: possible involvement of BAMBI promoter hypermethylation in metaplastic bone formation.
Kitazawa S; Kitazawa R; Obayashi C; Yamamoto T
J Bone Miner Res; 2005 Aug; 20(8):1472-7. PubMed ID: 16007344
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis.
Signoroni S; Frattini M; Negri T; Pastore E; Tamborini E; Casieri P; Orsenigo M; Da Riva L; Radice P; Sala P; Gronchi A; Bertario L; Pierotti MA; Pilotti S
Clin Cancer Res; 2007 Sep; 13(17):5034-40. PubMed ID: 17785554
[TBL] [Abstract][Full Text] [Related]
18. Desmoid and fibroma tumors differently respond to TGFbeta(1) stimulus and ECM macromolecule accumulation.
Locci P; Balducci C; Lilli C; Marinucci L; Becchetti E; Dolci C; Calastrini C; Lumare E; Stabellini G
Biomed Pharmacother; 2007; 61(2-3):131-6. PubMed ID: 17145161
[TBL] [Abstract][Full Text] [Related]
19. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.
Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC
Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042
[TBL] [Abstract][Full Text] [Related]
20. A rare sporadic pancreatic desmoid fibromatosis diagnosed by endoscopic ultrasound-guided fine-needle aspiration: Case report and literature review.
Stone AB; Mallery JS; Stewart J; Amin K
Diagn Cytopathol; 2021 Feb; 49(2):E49-E54. PubMed ID: 32857922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
